Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Clarke

Showing results (351-360 of 441) with videos related to

Pageof 45
Sort By:
Genes, Brain, and Behavior|March 27, 2012
Genetic association analyses of PDYN polymorphisms with heroin and cocaine addictionT-K Clarke, L Ambrose-Lanci, T N Ferraro, et al.
Infectious Agents and Disease|August 1, 1994
RNA virus quasispecies: significance for viral disease and epidemiologyE A Duarte, I S Novella, S C Weaver, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.
Cancer Chemotherapy and Pharmacology|April 2, 1998
Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.
Archives of Physiology and Biochemistry|December 26, 2007
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic miceO-J How, T S Larsen, A D Hafstad, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Journal of Virology|February 3, 2017
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus ChallengeFarooq Nasar, Demetrius Matassov, Robert L Seymour, et al.
Blood|May 1, 1997
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
The Pharmacogenomics Journal|October 16, 2013
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American femalesT-K Clarke, R C Crist, A Ang, et al.
Vaccine|May 12, 2009
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculationJ Erik Johnson, John W Coleman, Narender K Kalyan, et al.
Pageof 45

Showing results (351-360 of 441) with videos related to

Sort By:
Pageof 45
Genes, Brain, and Behavior|March 27, 2012
Genetic association analyses of PDYN polymorphisms with heroin and cocaine addictionT-K Clarke, L Ambrose-Lanci, T N Ferraro, et al.
Infectious Agents and Disease|August 1, 1994
RNA virus quasispecies: significance for viral disease and epidemiologyE A Duarte, I S Novella, S C Weaver, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.
Cancer Chemotherapy and Pharmacology|April 2, 1998
Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant diseaseD J Morgan, J S Hill, K Clarke, et al.
Archives of Physiology and Biochemistry|December 26, 2007
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic miceO-J How, T S Larsen, A D Hafstad, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Journal of Virology|February 3, 2017
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus ChallengeFarooq Nasar, Demetrius Matassov, Robert L Seymour, et al.
Blood|May 1, 1997
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
The Pharmacogenomics Journal|October 16, 2013
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American femalesT-K Clarke, R C Crist, A Ang, et al.
Vaccine|May 12, 2009
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculationJ Erik Johnson, John W Coleman, Narender K Kalyan, et al.
Pageof 45